Novo Nordisk A/S | NOVOB - 税引前利益





税引前利益 変化する 日付
Bausch Health Companies USD 348M 1.7B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
GlaxoSmithKline GBP 2.68B 532M 2026-06
Merck USD -3.53B 6.95B 2026-03
Novartis USD 4.27B 430M 2026-06
Novo Nordisk DKK 33.8B 3.23B 2025-06
Novo Nordisk DKK 62.17B 36.66B 2026-03
Pacira USD 5M 4.43M 2026-03
Sanofi EUR 837M 1.17B 2026-06
Supernus Pharmaceuticals USD -57.65M 51.7M 2026-06